Scientists at the Abu Dhabi Stem Cell Center (ADSCC) have professed to have built up a creative treatment for COVID-19 that utilizations undifferentiated cells to fix the disease.
As per ADSCC, the treatment includes extricating undifferentiated cells from the patient’s blood and reintroducing them in an actuated state to the lungs through inward breath of a fine fog.
The fog has a restorative impact as it empowers the lung cells to recover and change the reaction of the invulnerable framework. This prevents the insusceptible framework from going overboard to the COVID-19 disease and harming the sound cells.
According to the Emirates News Agency (WAM), the treatment has indicated promising outcomes in the main phase of clinical preliminaries.
73 reasonably or seriously sick Coronavirus patients, many intubated in an ICU, in the UAE were managed this treatment alongside standard treatment conventions for COVID-19 during this stage. Those patients made total recuperations from the disease, expressed WAM.
In the coming weeks, further preliminaries of the treatment will be completed to find out its adequacy. In the mean time, the UAE’s Ministry of Economy has allowed a patent to ADSCC for the further improvement of the promising treatment for COVID-19 infection.
The main drawbacks to this treatment are the time and assets required for the undeveloped cells however it could function as a temporary arrangement until an antibody is openly accessible.
